| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/27/2004 | CA2451588A1 Protein having active sulfate transporter activity and method for detecting canceration of tissue |
| 06/24/2004 | WO2004053501A2 Polarization-enhanced detector with gold nanorods for detecting nanoscale rotational motion and method therefor |
| 06/24/2004 | WO2004053496A1 Use of substances binding to hat for the diagnosis and treatment of squamous carcinomas of the lung |
| 06/24/2004 | WO2004053494A1 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) |
| 06/24/2004 | WO2004053491A1 Biosensor with rf signal transmission |
| 06/24/2004 | WO2004053486A1 Cca1 as an antifungal target |
| 06/24/2004 | WO2004053485A1 Bpl1 as an antifungal target |
| 06/24/2004 | WO2004053459A2 Compounds and mehtods of use thereof for assaying lysophospholipase d activity |
| 06/24/2004 | WO2004053457A2 Quantitative test for bacterial pathogens |
| 06/24/2004 | WO2004053454A2 Methods for detecting invasion of a cell |
| 06/24/2004 | WO2004053453A2 Modulation of bub 1-beta expression |
| 06/24/2004 | WO2004053452A2 Assays relating to toll-like receptor activity |
| 06/24/2004 | WO2004053169A1 Modulation of interleukin 18 expression |
| 06/24/2004 | WO2004053166A1 Nucleic acid detector and method of detecting targets within a sample |
| 06/24/2004 | WO2004053165A1 Methods and compositions relating to gradient exposed cells |
| 06/24/2004 | WO2004053164A1 Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations |
| 06/24/2004 | WO2004053163A1 Method for identifying, analyzing and/or cloning nucleic acid isoforms |
| 06/24/2004 | WO2004053162A1 Method of distinguishing drug-resistance of hepatitis b virus |
| 06/24/2004 | WO2004053161A1 Method for identification and/or authentication of articles |
| 06/24/2004 | WO2004053160A2 Method to analyze polymeric nucleic acid sequence variations |
| 06/24/2004 | WO2004053159A2 Oligonucleotide guided analysis of gene expression |
| 06/24/2004 | WO2004053158A1 Method and kit for detecting a risk for diabetes or a metabolic syndrome |
| 06/24/2004 | WO2004053157A2 Methods for diagnosing and treating schizophrenia |
| 06/24/2004 | WO2004053156A1 Detection, identification and differentiation of eubacterial taxa using a hybridization assay |
| 06/24/2004 | WO2004053155A1 Multiplex assay detection of pathogenic organisms |
| 06/24/2004 | WO2004053154A1 Magnetism based nucleic acid amplification |
| 06/24/2004 | WO2004053153A1 A reagent and method for determining the size of polynucleotides |
| 06/24/2004 | WO2004053152A1 Method of selecting a lipolytic enzyme |
| 06/24/2004 | WO2004053151A1 Evolved clostridial toxins with altered protease specificity |
| 06/24/2004 | WO2004053150A1 Mss4 as an antifungal target |
| 06/24/2004 | WO2004053149A1 Cgt1 as an antifungal target |
| 06/24/2004 | WO2004053148A1 Method for the detection of pathogenic gram positive bacteria from the genera staphylococcus, enterococcus and streptococcus |
| 06/24/2004 | WO2004053147A1 Process control based on analysis of microbial populations |
| 06/24/2004 | WO2004053146A2 Sec14 as an antifungal target |
| 06/24/2004 | WO2004053145A2 Trl1 as an antifungal target |
| 06/24/2004 | WO2004053144A2 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 06/24/2004 | WO2004053143A2 Concurrent enzymatic polynucleotide synthesis and detectable signal generation |
| 06/24/2004 | WO2004053141A2 Methods for rapid forensic analysis of mitochondrial dna and characterization of mitochondrial dna heteroplasmy |
| 06/24/2004 | WO2004053124A1 Method of screening remedy or preventive for diabetes |
| 06/24/2004 | WO2004053115A1 Magnetism based rapid cell separation |
| 06/24/2004 | WO2004053105A2 Direct snp detection with unamplified dna |
| 06/24/2004 | WO2004053099A2 A method for treatment of drug addiction and for screening of pharmaceutical agents therefor |
| 06/24/2004 | WO2004053085A2 Identification of genes involved in angiogenesis, and development of an angiogenesis diagnostic chip to identify patients with impaired angiogenesis |
| 06/24/2004 | WO2004053083A2 Modulation of fetoprotein transcription factor expression |
| 06/24/2004 | WO2004053076A2 Methods for rapid detection and identification of bioagents for environmental and product testing |
| 06/24/2004 | WO2004053074A2 Outcome prediction and risk classification in childhood leukemia |
| 06/24/2004 | WO2004053071A2 Method for discovering neurogenic agents |
| 06/24/2004 | WO2004053069A2 PROTECTION OF STEM CELLS FROM CYTOTOXIC AGENTS BY MODULATION OF β-CATENIN SIGNALING PATHWAYS |
| 06/24/2004 | WO2004053067A2 Methods for inhibiting cancer and scar formation |
| 06/24/2004 | WO2004053066A2 Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy |
| 06/24/2004 | WO2004053063A2 Molecular determinants of myeloma bone disease and uses thereof |
| 06/24/2004 | WO2004052934A1 Monitor protein for measuring processing of protein |
| 06/24/2004 | WO2004052918A2 Peptides and methods for deactivation of organophosphorus-based nerve agents and insecticides |
| 06/24/2004 | WO2004052907A1 Nucleic acid labeling compounds |
| 06/24/2004 | WO2004052606A2 Detection, identification and differentiation of eubacterial taxa using a hybridization assay |
| 06/24/2004 | WO2004052527A1 Method and reactor for the amplification of dna |
| 06/24/2004 | WO2004052404A2 Glycogen synthase kinase-3 inhibitors |
| 06/24/2004 | WO2004052309A2 Modulation of stat 6 expression |
| 06/24/2004 | WO2004052301A2 Modulation of matrix metalloproteinase 11 expression |
| 06/24/2004 | WO2004052300A2 Modulation of alpha-methylacyl-coa racemase expression |
| 06/24/2004 | WO2004052293A2 Recombinant vaccine against flavivirus infection |
| 06/24/2004 | WO2004052290A2 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 06/24/2004 | WO2004052285A2 Fat regulation |
| 06/24/2004 | WO2004052278A2 Escape mutants of newcastle disease virus as marker vaccines |
| 06/24/2004 | WO2004052186A2 Expressed genes that define the osteoclast phenotype |
| 06/24/2004 | WO2004052184A2 Genes related to sensitivity and resistance to chemotherapeutic drug treatment |
| 06/24/2004 | WO2004052175A2 Methods for rapid identification of pathogens in humans and animals |
| 06/24/2004 | WO2004052080A2 Regulome arrays |
| 06/24/2004 | WO2004040015A3 Method for analyzing a complex biological state of a biosystem and support for its direct interpretation |
| 06/24/2004 | WO2004038043A3 POLYMORPHISM IN THE Per3 GENE AS A INDICATOR IN THE DIAGNOSIS AND TREATMENT OF CIRCADIAN RHYTHM SLEEP DISORDERS |
| 06/24/2004 | WO2004035825A3 Marker gene |
| 06/24/2004 | WO2004034053A3 Sensor strip having a capillary flow channel with a flow terminating interface |
| 06/24/2004 | WO2004029300A3 Assay for the identification and quantification of clamydia pneumonia in atherosclerotic plaques by lightcycler real-time pcr |
| 06/24/2004 | WO2004029239A9 Crystal structure of chorismate synthase and uses thereof |
| 06/24/2004 | WO2004024883A3 PAKs AS MODIFIERS OF THE CHK PATHWAY AND METHODS OF USE |
| 06/24/2004 | WO2004024026A3 Method and device for monitoring platelet function |
| 06/24/2004 | WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 06/24/2004 | WO2004022575A3 Bioinformatics analysis of cellular effects of artificial transcription factors |
| 06/24/2004 | WO2004021986A3 Improved compositions and methods for cdna synthesis |
| 06/24/2004 | WO2004020980A3 Assays for the detection of biliverdin in birds and reptiles |
| 06/24/2004 | WO2004020653A3 Analytical method for the determination of infant formula protein digestibility in vitro |
| 06/24/2004 | WO2004019877A3 Nos-2 and glaucoma |
| 06/24/2004 | WO2004019043A3 Polypeptide biomarkers for diagnosing alzheimer's disease |
| 06/24/2004 | WO2004018998A3 Method using real-time pcr |
| 06/24/2004 | WO2004018632A3 High-throughput screen for modulators of chromatin modifying activity |
| 06/24/2004 | WO2004016227A3 Screening methods for cognitive enhancers |
| 06/24/2004 | WO2004015085A3 Method and compositions relating to 5’-chimeric ribonucleic acids |
| 06/24/2004 | WO2004011664A3 Protein or carbohydrate profiling |
| 06/24/2004 | WO2004003514A3 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 06/24/2004 | WO2004003513A3 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 06/24/2004 | WO2004003173A3 Method for detecting mutated polynucleotides within a large population of wild-type polynucleotides |
| 06/24/2004 | WO2003097795A3 Constitutively translocating cell line |
| 06/24/2004 | WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 06/24/2004 | WO2003087407A3 Methods and apparatus for genotyping |
| 06/24/2004 | WO2003086311A3 Methods for treating tweak-related conditions |
| 06/24/2004 | WO2003083129A3 Universal signal amplification tail |
| 06/24/2004 | WO2003076631A3 Genetic products differentially expressed in tumors and use thereof |
| 06/24/2004 | WO2003072716A3 Sequence analysis of the tetravalent rotavirus vaccine |
| 06/24/2004 | WO2003049686A3 Stabilization of hypoxia inducible factor (hif) alpha |
| 06/24/2004 | WO2003027264A3 Coisogenic eukaryotic cell collections |